SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis
USA - NASDAQ:SBC - US73245B1070 - Common Stock
3.15 USD
+0.07 (+2.27%)
3.15 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to SBC. SBC was compared to 100 industry peers in the Health Care Providers & Services industry. SBC has an excellent financial health rating, but there are some minor concerns on its profitability. SBC is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year SBC was profitable.
In the past year SBC has reported a negative cash flow from operations.
1.2 Ratios
SBC's Return On Assets of 10.57% is amongst the best of the industry. SBC outperforms 95.00% of its industry peers.
SBC has a better Return On Equity (13.63%) than 80.00% of its industry peers.
SBC's Return On Invested Capital of 22.45% is amongst the best of the industry. SBC outperforms 96.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.57% | ||
| ROE | 13.63% | ||
| ROIC | 22.45% |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 17.71%, SBC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
SBC's Operating Margin of 38.45% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
With an excellent Gross Margin value of 76.97%, SBC belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.45% | ||
| PM (TTM) | 17.71% | ||
| GM | 76.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SBC has less shares outstanding than it did 1 year ago.
The debt/assets ratio for SBC has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.77 indicates that SBC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.77, SBC belongs to the top of the industry, outperforming 87.00% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that SBC is not too dependend on debt financing.
SBC has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. SBC outperforms 81.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.77 |
ROIC/WACC2.51
WACC8.94%
2.3 Liquidity
A Current Ratio of 3.98 indicates that SBC has no problem at all paying its short term obligations.
The Current ratio of SBC (3.98) is better than 89.00% of its industry peers.
A Quick Ratio of 3.95 indicates that SBC has no problem at all paying its short term obligations.
SBC has a Quick ratio of 3.95. This is amongst the best in the industry. SBC outperforms 89.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.98 | ||
| Quick Ratio | 3.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 39.06% over the past year.
Looking at the last year, SBC shows a very strong growth in Revenue. The Revenue has grown by 74.40%.
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%
3.2 Future
SBC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.18% yearly.
SBC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.13% yearly.
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.00, the valuation of SBC can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 98.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.06. SBC is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 6.50, which indicates a rather cheap valuation of SBC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 98.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SBC to the average of the S&P500 Index (32.73), we can say SBC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7 | ||
| Fwd PE | 6.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 99.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.45 |
4.3 Compensation for Growth
A cheap valuation may be justified as SBC's earnings are expected to decrease with -10.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.18%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SBC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.15
+0.07 (+2.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.62%
Inst Owner ChangeN/A
Ins Owners89.24%
Ins Owner Change0%
Market Cap327.22M
Revenue(TTM)188.19M
Net Income(TTM)33.33M
Analysts80
Price Target7.91 (151.11%)
Short Float %1.13%
Short Ratio2.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.84%
Min EPS beat(2)-85.33%
Max EPS beat(2)89.02%
EPS beat(4)2
Avg EPS beat(4)-21.1%
Min EPS beat(4)-98.74%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.51%
Min Revenue beat(2)-9.04%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.89%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.66%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7 | ||
| Fwd PE | 6.5 | ||
| P/S | 1.74 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.34 | ||
| P/tB | 1.37 | ||
| EV/EBITDA | 2.45 |
EPS(TTM)0.45
EY14.29%
EPS(NY)0.48
Fwd EY15.39%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.81
BVpS2.35
TBVpS2.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.57% | ||
| ROE | 13.63% | ||
| ROCE | 28.42% | ||
| ROIC | 22.45% | ||
| ROICexc | 56.12% | ||
| ROICexgc | 60% | ||
| OM | 38.45% | ||
| PM (TTM) | 17.71% | ||
| GM | 76.97% | ||
| FCFM | N/A |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.1 | ||
| Cap/Depr | 96.72% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | 980.59 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.98 | ||
| Quick Ratio | 3.95 | ||
| Altman-Z | 5.77 |
F-Score5
WACC8.94%
ROIC/WACC2.51
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-567.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-391.7%
OCF growth 3YN/A
OCF growth 5YN/A
SBC MEDICAL GROUP HOLDINGS I / SBC FAQ
What is the fundamental rating for SBC stock?
ChartMill assigns a fundamental rating of 5 / 10 to SBC.
What is the valuation status for SBC stock?
ChartMill assigns a valuation rating of 6 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.
How profitable is SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 5 / 10.
Can you provide the financial health for SBC stock?
The financial health rating of SBC MEDICAL GROUP HOLDINGS I (SBC) is 7 / 10.
What is the expected EPS growth for SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -27.17% in the next year.